Chirfi Guindo
DirectoratBeam Therapeutics· In proxies 2024–2025
Chirfi Guindo sits on 1 public board.
Boards1
- Beam TherapeuticsDirector · 1 yr on the boardIndependentCompensation (Chair)—Paid as an executive
'%20d='M450.888,318.933h6.906v.949h-2.9v7.592H453.84v-7.592h-2.953Zm15.185,3.691h-4.9v-3.691h-1.054v8.541h1.054v-3.849h4.9v3.849h1.054v-8.541h-1.054Zm5.431,1h4.745v-1H471.5v-2.689h4.956v-1h-6.01v8.594h6.221v-1H471.5Zm12.285.686,2.794,3.163h-1.318l-2.689-3.058H480.52v3.058h-1.055v-8.541h3.9a2.671,2.671,0,0,1,2.9,2.742A2.462,2.462,0,0,1,483.789,324.311Zm-.527-.79a1.727,1.727,0,0,0,1.845-1.793,1.753,1.753,0,0,0-1.845-1.793h-2.795v3.585Zm9.965-4.587,3.848,8.541h-1.16l-.843-1.9h-4.9l-.844,1.9h-1.16l3.849-8.541Zm1.476,5.694-2.057-4.588-2,4.588Zm8.647.105H500.5v2.742h-1.055v-8.541h3.9A2.9,2.9,0,1,1,503.349,324.733Zm0-4.8H500.5v3.8h2.847A1.9,1.9,0,0,0,503.349,319.936Zm6.538,3.69h4.745v-1h-4.745v-2.689h4.956v-1h-6.011v8.594h6.222v-1h-5.167Zm13.813.475a2.455,2.455,0,1,1-4.9,0v-5.115h-1.054V324.1a3.481,3.481,0,1,0,6.96,0v-5.115h-1Zm3.27-4.218h2.953v7.592h1.054v-7.592h2.9v-.949H526.97Zm9.28,7.592H537.3v-8.541H536.25Zm8.277-.844a3.2,3.2,0,0,1-3.374-3.374,3.161,3.161,0,0,1,3.374-3.427,3.393,3.393,0,0,1,2.372.949l.738-.686a4.343,4.343,0,0,0-3.11-1.265,4.227,4.227,0,0,0-4.429,4.428,4.158,4.158,0,0,0,4.429,4.377,4.465,4.465,0,0,0,3.164-1.265l-.738-.738A3.346,3.346,0,0,1,544.527,326.63Zm8.7-4.007c-1.266-.211-2.32-.474-2.32-1.423,0-1.055,1.16-1.476,2.267-1.476a2.761,2.761,0,0,1,2.32,1l.791-.474a3.344,3.344,0,0,0-3.217-1.53c-1.476,0-3.269.58-3.269,2.373,0,1.74,1.635,2.109,3.269,2.372,1.318.211,2.479.527,2.479,1.582,0,1.266-1.371,1.582-2.426,1.582a3.067,3.067,0,0,1-2.742-1.476l-.9.527a3.7,3.7,0,0,0,3.639,2c1.634,0,3.48-.633,3.48-2.531S554.914,322.887,553.227,322.623Zm-90.16-9.121h-12.18V285.611h12.18c5.062,0,9.333,2.531,9.333,7.8a6.1,6.1,0,0,1-4.114,5.747,6.942,6.942,0,0,1,5.01,6.643C473.3,311.71,468.34,313.5,463.068,313.5Zm-8.7-15.923h8.858c3.322,0,5.747-1.212,5.747-4.112,0-3.11-2.531-4.692-5.905-4.692h-8.7Zm0,12.6h8.7c2.9,0,6.749-.738,6.749-4.534-.053-3.48-3.585-4.956-6.591-4.956h-8.858Zm32.426,3.638c-6.063,0-10.334-4.007-10.334-10.281a9.833,9.833,0,0,1,10.176-10.176c6.011,0,10.6,3.691,9.807,11.547H479.729c.369,3.638,3.321,5.905,7.117,5.905,2.215,0,4.956-.9,6.222-2.479l2.215,2C493.279,312.711,489.851,313.819,486.793,313.819Zm-7.012-11.652,13.6.053c-.159-3.8-2.794-5.905-6.643-5.905A6.7,6.7,0,0,0,479.781,302.167Zm40.6,11.336h-3.163l-.052.053-.105-3.585a8.3,8.3,0,0,1-7.223,3.955c-5.642,0-10.071-3.9-10.071-10.282s4.481-10.176,10.123-10.123a8.247,8.247,0,0,1,7.276,3.9l.052-3.585h3.163Zm-10.386-16.924a7.2,7.2,0,0,0,0,14.394C519.483,310.972,519.483,296.578,509.993,296.578Zm43.34,5.694V313.45H556.6V302.219c0-5.378-3.11-8.752-8.277-8.752a7.315,7.315,0,0,0-6.908,4.271c-1.107-3.111-3.9-4.271-6.59-4.271a6.3,6.3,0,0,0-5.8,3.217l-.211-2.847H525.81L525.7,313.45h3.269V302.325c0-3.216,2.109-5.747,5.325-5.747,3.268,0,5.273,2.531,5.273,5.747V313.45h3.269V302.325c0-3.216,2.161-5.747,5.378-5.747C551.488,296.578,553.333,299.056,553.333,302.272ZM450.308,269.056a25.12,25.12,0,0,0-3.48,1.371l4.534,6.221Zm-14.5,10.6,7.012,3.27-4.587-6.169A32.115,32.115,0,0,0,435.808,279.653Zm1.423-7.54,10.809,8.911-5.273-12.917A52.977,52.977,0,0,0,437.232,272.113Zm48.93,13.6a25.049,25.049,0,0,0-1.634-3.374l-5.958,4.9ZM431.274,289.3a29.46,29.46,0,0,0-.738,3.744l7.8-.475Zm2.689-6.7a28.869,28.869,0,0,0-1.635,3.427l7.645,1.424Zm40.6-10.6-2.794,7.118,5.853-4.956A24.584,24.584,0,0,0,474.561,272.008Zm-17.135-4.323c-1.266.106-2.479.263-3.691.475l2.794,7.117ZM467.971,269l-.949,7.592,4.429-6.222A19.889,19.889,0,0,0,467.971,269Zm-37.646,27.522a30.9,30.9,0,0,0,.211,3.849l7.487-2.479Zm52.251-17.083a30.79,30.79,0,0,0-2.426-2.9l-4.481,6.222Zm-51.355,24.306a30.261,30.261,0,0,0,1.213,3.691l6.643-4.27ZM464.6,268.16c-.633-.105-1.213-.212-1.846-.264s-1.265-.105-1.845-.158l.949,7.539Zm-28.63,45.607,5.378-5.8-7.486,2.531A26.612,26.612,0,0,0,435.966,313.766Z'%20transform='translate(-430.325%20-267.685)'%20fill='%23fff'/%3e%3c/g%3e%3c/svg%3e)
Board seats come from each company's latest proxy statement.
Experience
- Beam TherapeuticsPublic company · 2 yr
- Director2024 – Present · 2 yrStock in role -3%
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?